Does LEFLUNOMIDE Cause Basal cell carcinoma? 657 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 657 reports of Basal cell carcinoma have been filed in association with LEFLUNOMIDE (Leflunomide). This represents 1.2% of all adverse event reports for LEFLUNOMIDE.
657
Reports of Basal cell carcinoma with LEFLUNOMIDE
1.2%
of all LEFLUNOMIDE reports
3
Deaths
583
Hospitalizations
How Dangerous Is Basal cell carcinoma From LEFLUNOMIDE?
Of the 657 reports, 3 (0.5%) resulted in death, 583 (88.7%) required hospitalization, and 21 (3.2%) were considered life-threatening.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEFLUNOMIDE. However, 657 reports have been filed with the FAERS database.
What Other Side Effects Does LEFLUNOMIDE Cause?
Drug ineffective (31,396)
Rheumatoid arthritis (20,886)
Pain (15,594)
Drug intolerance (14,142)
Joint swelling (13,026)
Fatigue (11,959)
Arthralgia (11,880)
Rash (11,239)
Contraindicated product administered (11,206)
Abdominal discomfort (10,333)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
ALENDRONATE (610)
Which LEFLUNOMIDE Alternatives Have Lower Basal cell carcinoma Risk?
LEFLUNOMIDE vs LEMBOREXANT
LEFLUNOMIDE vs LENACAPAVIR
LEFLUNOMIDE vs LENALIDOMIDE
LEFLUNOMIDE vs LENIOLISIB
LEFLUNOMIDE vs LENOGRASTIM